Merck and GE Healthcare collaborate on use of imaging biomarkers for investigational BACE inhibitor clinical development program
18 December 2012 | By Merck
Clinical study collaboration announced...
List view / Grid view
News
GSK and Theravance announce regulatory submission for UMEC/VI (LAMA/LABA) in the US
18 December 2012 | By GlaxoSmithKline
ANORO ELLIPTA™ proposed proprietary name for UMEC/VI...
Sanofi President, Global Operations, to retire
18 December 2012 | By Sanofi
Sanofi announced that Hanspeter Spek, President, Global Operations, will retire from his current role in mid-2013...
Roche launches new cobas b 101 system for management of metabolic syndrome
18 December 2012 | By Roche
Roche announced the global launch (excluding US) of cobas b 101...
Abbott announces new testosterone test to measure the hormone at low levels
17 December 2012 | By Abbott
New assay measures testosterone levels to help diagnose related conditions...
ViiV Healthcare announces regulatory submissions for dolutegravir in the EU, US and Canada
17 December 2012 | By GlaxoSmithKline
“These regulatory submissions are an important step for ViiV Healthcare..."
Teva enters agreement with Handok to establish business venture with significant presence in Korean pharmaceutical market
16 December 2012 | By Teva Pharmaceutical Industries Ltd
TEVA and Handok announced agreement...
Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing’s disease, a serious endocrine disorder
15 December 2012 | By Novartis
The US FDA has approved Signifor®...
Genzyme and Isis provide update on CHMP opinion on KYNAMRO™ (mipomersen)
14 December 2012 | By Sanofi
"We are disappointed by the Committee's recommendation..."
Roche’s breast cancer treatment Perjeta receives recommendation for approval in EU
14 December 2012 | By Roche
Positive opinion for the use of Perjeta (pertuzumab)...
GSK receives FDA approval for raxibacumab anti-toxin for the treatment of inhalational anthrax
14 December 2012 | By GlaxoSmithKline
The U.S. FDA has approved raxibacumab...
Amgen announces appointment of Robert A. Eckert to Board of Directors
13 December 2012 | By Amgen
Amgen announced the appointment of Robert A. Eckert to its Board of Directors...
AstraZeneca announces top-line results of OSKIRA-4 Phase IIb study of fostamatinib as a monotherapy for rheumatoid arthritis
13 December 2012 | By AstraZeneca
Top-line results of OSKIRA-4...
New study shows promising results for tests that can help doctors better evaluate potential heart attacks
13 December 2012 | By Abbott
Acute chest pain is one of the most common reasons people seek emergency care...
Amgen names Robert A. Bradway Chairman of the Board of Directors
13 December 2012 | By Amgen
Amgen announced appointments to its Board of Directors...
